National Institute for Health Research and IQVIA invests in clinical trials

The National Institute for Health Research (NIHR) and IQVIA – the global health technology and human data science company – are today inaugurating their Northern Prime Site, focusing on the delivery of life-changing clinical research across the North of England.

The site is the fourth IQVIA Prime Site in the UK and will employ more than 50 newly recruited staff to support an increase in clinical trials and real-world evidence studies within the region over the coming years.

IQVIA currently conducts more than 20% of all commercial clinical trials in the NHS and the Northern Prime Site will bring together NHS research-ready hospitals across Greater Manchester and the Yorkshire and Humber region.

The Prime Site will embrace a health data-enabled, technology-rich approach to the design and delivery of hundreds of additional clinical trials and real-world evidence studies which have the potential of transforming healthcare outcomes for thousands of NHS patients.

The initiative is part of IQVIA’s plans to invest £24m in the North of England regional health economy.

Tim Sheppard, Senior Vice President & GM UKI & Northern Europe, IQVIA said: “This is a transformational step forward for clinical research in the North of England. We believe that this new collaboration between IQVIA and the NIHR with data enabled researchers across the North of England will be a win/win for local patients and the wider economy.”

“Our Prime Sites bring new investment in clinical trials that further cements the UK’s reputation as a primary location for world-leading research. This newest site across Greater Manchester, Leeds and Sheffield ensures that patients will now have even more access to innovative trials, which hold the promise of transforming health outcomes in the future.”